Gain Therapeutics (NASDAQ:GANX – Get Free Report) released its quarterly earnings data on Tuesday. Gain Therapeutics Stock PerformanceShares of NASDAQ:GANX traded up $0.17 on Tuesday, hitting $1.94. Get Gain Therapeutics alerts:Institutional Trading of Gain TherapeuticsInstitutional investors and hedge funds have recently modified their holdings of the stock. Finally, Wall Street Zen upgraded Gain Therapeutics from a “strong sell” rating to a “sell” rating in a report on Sunday, June 21st. See AlsoReceive News & Ratings for Gain Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gain Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.